Befejeződött1. fázis
A Study Evaluating Pharmacokinetic Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Stage III and Stage IV Melanoma in the Adjuvant Setting
Key facts
- Where
- Ancona, Bari, Bergamo, Meldola, Milan, Naples, Pavia, Rome, Siena és Varese, OlaszországSee the 12 sites
- Phase
- 1. fázis
Where in Olaszország
- Azienda Ospedaliero-Universitaria delle MarcheAncona, OlaszországNo longer taking part
- Istituto Tumori Bari Giovanni Paolo IIBari, OlaszországNo longer taking part
- Azienda Ospedaliera Papa Giovanni XXIIIBergamo, OlaszországNo longer taking part
- Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.lMeldola, OlaszországNo longer taking part
- European Institute Of Oncology S.r.l.Milan, OlaszországNo longer taking part
- Ospedale San Raffaele S.r.l.Milan, OlaszországNo longer taking part
- Azienda Ospedaliera Universitaria Federico II Di NapoliNaples, OlaszországNo longer taking part
- Fondazione IRCCS Policlinico San MatteoPavia, OlaszországNo longer taking part
- Fondazione Luigi Maria MontiRome, OlaszországNo longer taking part
- Fondazione Policlinico Universitario Campus Bio-MedicoRome, OlaszországNo longer taking part
- Azienda Ospedaliera Universitaria SeneseSiena, OlaszországNo longer taking part
- Azienda Ospedaliera Ospedale Di Circolo E Fondazione MacchiVarese, OlaszországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Amgen Inc.
- Trial code
- EU 2022-502620-49-00
- Record updated
- 2025. december 5.